This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Looking at the future use of the CanGaroo RM Antibacterial Envelope from Aziyo Biologics

Ticker(s): AZYO, MDT

Who's the expert?

Institution: PeaceHealth Sacred Heart Medical Center

  • Cardiac Electrophysiologist at PeaceHealth Sacred Heart Medical Center who implants 8-10 CIEDs every month
  • Frequently utilizes envelopes for CIED protection, including the Medtronic Tyrx and Aziyo Cangaroo
  • Clinical Interest in congenital heart defects, coronary artery disease, heart rhythm disorders and heart failure.

Interview Questions
Q1.

Please describe your background and practice setting.

Added By: ben_admin
Q2.

How many cardiac implantable electronic devices do you implant on a monthly basis?

Added By: ben_admin
Q3.

How many of the CanGaroo envelopes have you utilized in the past 12 months?

Added By: ben_admin
Q4.

What is your opinion on the next generation device, utilizing rifampin and minocycline for bacterial protection?

Added By: ben_admin
Q5.

What do you think of the 'Not Substantially Equivalent determination' from the FDA? How will it impact the future of this envelope?

Added By: ben_admin
Q6.

What is your opinion of the Clinical Data on the CanGaroo® Biologic Envelope- Study Presented at Heart Rhythm Society

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.